CyberSenga: Internet-based HIV Prevention in Uganda

Sponsor
Center for Innovative Public Health Research (Other)
Overall Status
Completed
CT.gov ID
NCT00906178
Collaborator
Mbarara University of Science and Technology (Other), Harvard University (Other), University of Colorado, Denver (Other), Internet Solutions for Kids Uganda, Limited (Other), National Institute of Mental Health (NIMH) (NIH)
366
1
2
50
7.3

Study Details

Study Description

Brief Summary

The investigators propose to design and test an Internet-based HIV prevention program for adolescents in Uganda.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: CyberSenga
Phase 1

Detailed Description

HIV/AIDS is a major contributor to morbidity and mortality in Uganda. Despite aggressive advances in HIV prevention efforts, recent data suggest that HIV prevalence is increasing generally, and HIV knowledge, a direct contributor to behavior, is on the decline among young people specifically as compared to a decade ago.

The Internet is a promising mode of intervention delivery in resource poor-settings because the costs associated with scaling up are minimal; dissemination online is the same if one person or 100,000 people use the program. Just as important, it provides access to important health information in a stigma-free, anonymous atmosphere. Our recent data indicate that 45% of adolescents in Mbarara, Uganda have used the Internet, 78% of whom went online at least once in the previous week. Eighty-one percent of respondents in the same survey indicated they would go to an HIV prevention web site if it existed. Based upon these data, we propose to develop a culturally appropriate, Internet-based HIV prevention program designed specifically for Ugandan adolescents between the ages of 12 and 18 years. Our specific aims are as follows:

Specific Aim 1: Design a 6-hour, Internet-based HIV prevention program for adolescents. Content will be culturally tailored to the HIV preventive information, motivation, and behavioral skills needs of Ugandan adolescents.

Specific Aim 2: Test the intervention in a randomized controlled trial (n=500) among adolescents attending grades Secondary 1-4 (similar to US high school grades 8th - 11th) at day schools in Mbarara.

This project has the potential to develop low-cost and salable interventions to HIV transmission risk behaviors among adolescents in Uganda.

Study Design

Study Type:
Interventional
Actual Enrollment :
366 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
CyberSenga: Harnessing the Power of the Internet to Prevent HIV in Ugandan Youth
Study Start Date :
Aug 1, 2007
Actual Primary Completion Date :
Oct 1, 2011
Actual Study Completion Date :
Oct 1, 2011

Arms and Interventions

Arm Intervention/Treatment
Experimental: CyberSenga

6-module HIV prevention program tailored for adolescents in Uganda

Behavioral: CyberSenga
Internet-based HIV prevention program

No Intervention: Control

"treatment as usual" - the sexual health education adolescents currently receive in secondary school

Outcome Measures

Primary Outcome Measures

  1. Sex Without a Condom as Assessed by Self-report [6-months post-intervention]

    Unprotected sex (i.e., vaginal or anal sex without a condom) in the past three months

  2. Sexual Abstinence [6-months post-intervention]

    Not having had vaginal or anal sex in the past three months

Secondary Outcome Measures

  1. Abstinence at Three-month Follow-up [3 months post-intervention]

    Sexual abstinence (i.e., not having vaginal or anal sex) in the past 90 days

  2. Unprotected Sex at Three-month Follow-up [3 months post-intervention]

    Ever had vaginal or anal sex without a condom in the past 90 days

Eligibility Criteria

Criteria

Ages Eligible for Study:
12 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Enrollment in grades Secondary 1 through 4 at a partner secondary school

  • Having used a computer or the Internet at least once in the past year

  • Not having been part of the intervention development activities

  • Caregiver informed permission and adolescent informed assent

Exclusion Criteria:
  • none

Contacts and Locations

Locations

Site City State Country Postal Code
1 Internet Solutions for Kids Uganda, Limited Mbarara Uganda

Sponsors and Collaborators

  • Center for Innovative Public Health Research
  • Mbarara University of Science and Technology
  • Harvard University
  • University of Colorado, Denver
  • Internet Solutions for Kids Uganda, Limited
  • National Institute of Mental Health (NIMH)

Investigators

  • Principal Investigator: Michele Ybarra, MPH PhD, Center for Innovative Public Health

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
Center for Innovative Public Health Research
ClinicalTrials.gov Identifier:
NCT00906178
Other Study ID Numbers:
  • ISK-NIH-MH080662
  • 5R01MH080662
First Posted:
May 21, 2009
Last Update Posted:
Aug 11, 2016
Last Verified:
Jun 1, 2016
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by Center for Innovative Public Health Research

Study Results

Participant Flow

Recruitment Details We aimed to screen all 382 female students enrolled in the two mixed-sex schools and 772 of the 2,264 male students enrolled across the four schools to identify 400 eligible youth. Many youth were out of school trying to secure school fees or had changed schools. As a result, 740 of the youth were screened, 416 of whom were eligible (56%).
Pre-assignment Detail
Arm/Group Title HIV Prevention Control
Arm/Group Description 6-module HIV prevention program tailored for adolescents in Uganda CybereSenga: Internet-based HIV prevention program "treatment as usual" - the sexual health education adolescents currently receive in secondary school CybereSenga: Internet-based HIV prevention program
Period Title: Overall Study
STARTED 183 183
COMPLETED 168 167
NOT COMPLETED 15 16

Baseline Characteristics

Arm/Group Title HIV Prevention Control Total
Arm/Group Description 6-module HIV prevention program tailored for adolescents in Uganda CybereSenga: Internet-based HIV prevention program "treatment as usual" - the sexual health education adolescents currently receive in secondary school CybereSenga: Internet-based HIV prevention program Total of all reporting groups
Overall Participants 183 183 366
Age (years) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [years]
16.0
(1.4)
16.2
(1.5)
16.1
(1.4)
Sex: Female, Male (Count of Participants)
Female
31
16.9%
28
15.3%
59
16.1%
Male
152
83.1%
155
84.7%
307
83.9%
Grade (participants) [Number]
Secondary 2
47
25.7%
50
27.3%
97
26.5%
Secondary 3
73
39.9%
58
31.7%
131
35.8%
Secondary 4
63
34.4%
75
41%
138
37.7%
Maternal Education (participants) [Number]
Primary School or Less/Don't Know
60
32.8%
63
34.4%
123
33.6%
More Than Primary School
123
67.2%
120
65.6%
243
66.4%
Paternal Education (participants) [Number]
Primary School or Less/Don't Know
48
26.2%
50
27.3%
98
26.8%
More Than Primary School
135
73.8%
133
72.7%
268
73.2%
Internet Use (participants) [Number]
Infrequent
101
55.2%
102
55.7%
203
55.5%
Frequent
82
44.8%
81
44.3%
163
44.5%
Ever Had Oral Sex (participants) [Number]
Yes
19
10.4%
17
9.3%
36
9.8%
No
164
89.6%
166
90.7%
330
90.2%
Ever Had Vaginal Sex (participants) [Number]
Yes
58
31.7%
55
30.1%
113
30.9%
No
125
68.3%
128
69.9%
253
69.1%
Ever Had Anal Sex (participants) [Number]
Yes
4
2.2%
5
2.7%
9
2.5%
No
179
97.8%
178
97.3%
357
97.5%
Ever Been Tested for HIV (participants) [Number]
Yes
75
41%
64
35%
139
38%
No
108
59%
119
65%
227
62%
Ever known someone who died from AIDS (participants) [Number]
Yes
67
36.6%
71
38.8%
138
37.7%
No
116
63.4%
112
61.2%
228
62.3%
Tired of hearing about HIV prevention information (participants) [Number]
Somewhat/strongly agree
45
24.6%
49
26.8%
94
25.7%
Do not Somewhat/strongly agree
138
75.4%
134
73.2%
272
74.3%
Above average change of getting HIV (participants) [Number]
Yes
12
6.6%
12
6.6%
24
6.6%
No
171
93.4%
171
93.4%
342
93.4%
Beliefs supportive of HIV Stigma (units on a scale) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [units on a scale]
1.1
(.9)
1.2
(1.1)
1.1
(1.0)
Ever had a boyfriend/girlfriend (participants) [Number]
Yes
141
77%
137
74.9%
278
76%
No
42
23%
46
25.1%
88
24%
Ever been a victim of teen dating violence (participants) [Number]
Yes
35
19.1%
43
23.5%
78
21.3%
No
148
80.9%
140
76.5%
288
78.7%
Ever been a perpetrator of teen dating violence (participants) [Number]
Yes
28
15.3%
37
20.2%
65
17.8%
No
155
84.7%
146
79.8%
301
82.2%
Beliefs consistent with female empowerment in relationships (units on a scale) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [units on a scale]
8.2
(2.8)
8.0
(2.8)
8.1
(2.8)
Fair or poor health (participants) [Number]
Yes
35
19.1%
24
13.1%
59
16.1%
No
148
80.9%
159
86.9%
307
83.9%
Bright future somewhat/very unlikely (participants) [Number]
Yes
20
10.9%
15
8.2%
35
9.6%
No
163
89.1%
168
91.8%
331
90.4%
Wish to have more self-respect (participants) [Number]
Yes
149
81.4%
144
78.7%
293
80.1%
No
34
18.6%
39
21.3%
73
19.9%
The Multidimensional Scale of Perceived Social Support : Social support from "special person" (units on a scale) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [units on a scale]
16.7
(2.8)
16.2
(4.1)
16.5
(4.0)
The Multidimensional Scale of Perceived Social Support: Social support from family (units on a scale) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [units on a scale]
17.1
(3.1)
17.7
(3.0)
17.4
(3.1)
Information (participants) [Number]
Yes
86
47%
97
53%
183
50%
No
97
53%
86
47%
183
50%
Motivation: Attitudes towards HIV preventive acts (units on a scale) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [units on a scale]
3.6
(.9)
3.5
(.9)
3.6
(.9)
Motivation: Subjective norms regarding HIV preventive acts (units on a scale) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [units on a scale]
3.6
(.9)
3.5
(.9)
3.6
(.9)
Motivation: Behavioral intentions for HIV prevention (units on a scale) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [units on a scale]
3.5
(.9)
3.5
(.9)
3.5
(.9)
Behavioral Skills (units on a scale) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [units on a scale]
2.9
(.7)
2.9
(.7)
2.9
(.7)

Outcome Measures

1. Primary Outcome
Title Sex Without a Condom as Assessed by Self-report
Description Unprotected sex (i.e., vaginal or anal sex without a condom) in the past three months
Time Frame 6-months post-intervention

Outcome Measure Data

Analysis Population Description
ITT - Intention to Treat
Arm/Group Title HIV Prevention Control
Arm/Group Description 6-module HIV prevention program tailored for adolescents in Uganda CybereSenga: Internet-based HIV prevention program "treatment as usual" - the sexual health education adolescents currently receive in secondary school CybereSenga: Internet-based HIV prevention program
Measure Participants 183 183
Number [participants]
26
14.2%
24
13.1%
Statistical Analysis 1
Statistical Analysis Overview Comparison Group Selection HIV Prevention, Control
Comments
Type of Statistical Test Superiority or Other
Comments
Statistical Test of Hypothesis p-Value
Comments
Method
Comments
Method of Estimation Estimation Parameter Odds Ratio (OR)
Estimated Value 1.05
Confidence Interval (2-Sided) 95%
.57 to 1.94
Parameter Dispersion Type:
Value:
Estimation Comments
2. Primary Outcome
Title Sexual Abstinence
Description Not having had vaginal or anal sex in the past three months
Time Frame 6-months post-intervention

Outcome Measure Data

Analysis Population Description
ITT - Intention to Treat
Arm/Group Title HIV Prevention Control
Arm/Group Description 6-module HIV prevention program tailored for adolescents in Uganda CybereSenga: Internet-based HIV prevention program "treatment as usual" - the sexual health education adolescents currently receive in secondary school CybereSenga: Internet-based HIV prevention program
Measure Participants 183 183
Number [participants]
138
75.4%
137
74.9%
Statistical Analysis 1
Statistical Analysis Overview Comparison Group Selection HIV Prevention, Control
Comments
Type of Statistical Test Superiority or Other
Comments
Statistical Test of Hypothesis p-Value
Comments
Method
Comments
Method of Estimation Estimation Parameter Odds Ratio (OR)
Estimated Value 1.01
Confidence Interval (2-Sided) 95%
.62 to 1.65
Parameter Dispersion Type:
Value:
Estimation Comments
3. Secondary Outcome
Title Abstinence at Three-month Follow-up
Description Sexual abstinence (i.e., not having vaginal or anal sex) in the past 90 days
Time Frame 3 months post-intervention

Outcome Measure Data

Analysis Population Description
ITT--Intention to Treat
Arm/Group Title HIV Prevention Control
Arm/Group Description 6-module HIV prevention program tailored for adolescents in Uganda CybereSenga: Internet-based HIV prevention program "treatment as usual" - the sexual health education adolescents currently receive in secondary school CybereSenga: Internet-based HIV prevention program
Measure Participants 183 183
Number [participants]
135
73.8%
149
81.4%
Statistical Analysis 1
Statistical Analysis Overview Comparison Group Selection HIV Prevention, Control
Comments
Type of Statistical Test Superiority or Other
Comments
Statistical Test of Hypothesis p-Value
Comments
Method
Comments
Method of Estimation Estimation Parameter Odds Ratio (OR)
Estimated Value 1.56
Confidence Interval (2-Sided) 95%
.93 to 2.62
Parameter Dispersion Type:
Value:
Estimation Comments
4. Secondary Outcome
Title Unprotected Sex at Three-month Follow-up
Description Ever had vaginal or anal sex without a condom in the past 90 days
Time Frame 3 months post-intervention

Outcome Measure Data

Analysis Population Description
ITT--Intention to Treat
Arm/Group Title HIV Prevention Control
Arm/Group Description 6-module HIV prevention program tailored for adolescents in Uganda CybereSenga: Internet-based HIV prevention program "treatment as usual" - the sexual health education adolescents currently receive in secondary school CybereSenga: Internet-based HIV prevention program
Measure Participants 183 183
Number [participants]
21
11.5%
28
15.3%
Statistical Analysis 1
Statistical Analysis Overview Comparison Group Selection HIV Prevention, Control
Comments
Type of Statistical Test Superiority or Other
Comments
Statistical Test of Hypothesis p-Value
Comments
Method
Comments
Method of Estimation Estimation Parameter Odds Ratio (OR)
Estimated Value .70
Confidence Interval (2-Sided) 95%
.37 to 1.30
Parameter Dispersion Type:
Value:
Estimation Comments

Adverse Events

Time Frame Adverse event data were collected through the study period (i.e., from baseline to 6 month follow-up).
Adverse Event Reporting Description
Arm/Group Title HIV Prevention Control
Arm/Group Description 6-module HIV prevention program tailored for adolescents in Uganda CybereSenga: Internet-based HIV prevention program "treatment as usual" - the sexual health education adolescents currently receive in secondary school CybereSenga: Internet-based HIV prevention program
All Cause Mortality
HIV Prevention Control
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total / (NaN) / (NaN)
Serious Adverse Events
HIV Prevention Control
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/183 (0%) 0/183 (0%)
Other (Not Including Serious) Adverse Events
HIV Prevention Control
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/183 (0%) 0/183 (0%)

Limitations/Caveats

Sexual activity in adolescence is a stigmatized behavior in Uganda, especially for females. Youth may have under-reported their sexual experiences, which in the intervention group would have led to them being triaged to the incorrect content.

More Information

Certain Agreements

All Principal Investigators ARE employed by the organization sponsoring the study.

There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

Results Point of Contact

Name/Title Dr. Michele Ybarra
Organization Center for Innovative Public Health Reserch
Phone 877-302-6858 ext 1-801#
Email michele@innovativepublichealth.org
Responsible Party:
Center for Innovative Public Health Research
ClinicalTrials.gov Identifier:
NCT00906178
Other Study ID Numbers:
  • ISK-NIH-MH080662
  • 5R01MH080662
First Posted:
May 21, 2009
Last Update Posted:
Aug 11, 2016
Last Verified:
Jun 1, 2016